EP2654736
Ný lyfjasamsetning
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
20.12.2011EP published:
1.7.2020EP application number:
11849974.8
EP translation filed:
8.9.2020Grant published:
15.10.2020EPO information:
European Patent Register
Max expiry date:
19.12.2031Expiry date:
19.12.2025
Title:
NOVEL PHARMACEUTICAL COMPOSITION
Timeline
Today
20.12.2011EP application
1.7.2020EP Publication
8.9.2020Translation submitted
15.10.2020Registration published
19.12.2025Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
DeMARINI, Douglas, J.Address:
Collegeville PA 19426, US
Name:
LE, Ngocdiep, T.Address:
Collegevill PA 19426, US
Name:
HENRIQUEZ, FranciscoAddress:
Collegeville PA 19426, US
Name:
WANG, LihongAddress:
Collegevill PA 19426, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201061424967 PDate:
20.12.2010Country:
US
Classification
Categories:
A61K 9/28, A61K 9/20, A61K 31/519, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 30.11.2020
Expires: 19.12.2021
Payer: Árnason Faktor ehf.
Number: 11
Paid: 24.11.2021
Expires: 19.12.2022
Payer: Árnason Faktor ehf.
Number: 12
Paid: 30.11.2022
Expires: 19.12.2023
Payer: Árnason Faktor ehf.
Number: 13
Paid: 12.12.2023
Expires: 19.12.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 28.11.2024
Expires: 19.12.2025
Payer: Árnason Faktor ehf.